Human Allograft Tissue
Home / About Human Allograft Tissue

About Human Allograft Tissue

Learn more about Surgilogix’s human tissue allografts.

Physicians and their patients often have questions about the human allograft* tissue used in Surgilogix products. We hear questions like, “Where do the tissues come from?”, “Are amniotic tissue grafts safe?” and “What makes an amniotic membrane graft a good option for me?” We’ve answered some of the most common questions below. If you have additional questions, please let us know.

Amniotic Tissue

Q: What is Amniotic Tissue?

Amniotic tissue makes up the inner most portion of a woman’s placenta during pregnancy. It consists of amniotic membrane and amniotic fluid.

Amniotic membrane is made up of two layers, chorion on the outside and amnion on the inside. The amnion surrounds and contains the amniotic fluid. Amniotic fluid surrounds and protects the growing embryo/fetus.


Amniotic tissue contains vital nutrients and growth factors that are essential for fetal growth, protection, and healing.

Q: Where does Amniotic Tissue Come From?

Obtaining amniotic tissue for allografts causes no Harm to the Mother or Child

Amniotic tissue collection DOES NOT require fetal sacrifice.

The amniotic tissues used in Surgilogix allografts are donated by consenting, healthy women between the ages of 18 – 45 who have just delivered a full-term, healthy baby through elective Cesarean section. A careful medical and social history is collected in advance to ensure donor mothers meet all eligibility requirements. Donor blood samples are collected and thoroughly screened for communicable diseases.

Q: How is Amniotic Tissue Classified by the FDA?

The US Food and Drug Administration (FDA) classifies amniotic tissue as a HCT/P (Human Cells, Tissues, and Cellular and Tissue-Based Products). An HCT/P is regulated solely under section 361 of the PHS Act and 21 CFR part 1271 if it meets all the following criteria (21 CFR 1271.10(a)): the tissue is minimally manipulated, intended for homologous use and is not combined with other cells or tissues. There can be no systemic effect or dependence on the metabolic activity of living cells to achieve its primary function and the tissue has to have a localized effect in vivo.”

If an HCT/P does not meet all of the criteria in 21 CFR 1271.10(a) it will be regulated as a drug, device, and/or biological product and a pre-market review would be required.

Q: Is Obtaining Amniotic Tissue Ethical?

Collection of placental tissues causes absolutely no harm to the new born baby or mother.

Amniotic tissue, which includes amniotic membrane and amniotic fluid, is taken from the inner most layer of the placenta. The placenta is collected AFTER a live birth delivered via elective cesarean section. The mother has volunteered to donate her placental tissues, which are typically discarded after the birth. Placental / amniotic tissue collection DOES NOT require fetal sacrifice.

Q: How is Amniotic Tissue Collected and Processed?

  • COLLECTION
  • Placental tissues are collected at several facilities around the country, following strict guidelines and consistent with industry best practices. At the time of Cesarean delivery (also known as C-section), the baby is delivered and the placenta and amniotic fluid, which are typically discarded, are saved. There is no harm to the new born baby or mother. All tissues are then tested to ensure viability and safety.


  • PROCESSING
  • The collected placental tissues (amniotic membrane and amniotic fluid) are processed to the highest standards in a state-of-the-art American Association of Tissue Banks (AATB) accredited facility. Our process maintains the original characteristics of the amniotic tissue including its cellular components, growth factors, and collagen, and keeps the extracellular matrix intact. This specialized technique results in a graft that maintains the original healing characteristics and protective barrier properties of the amniotic tissue. All processed tissues are tested per USP guidelines prior to release.

    Q: Why is Amniotic Tissue used in Wound Repair?

    Amniotic tissue is a regenerative biofactory, with key components known to optimize the wound healing environment.

    Its unique make-up:

    • viral1

      Includes cytokines, amino acids, carbohydrates, hyaluronic acid, and cellular components.1

    • viral2

      Contains key growth factors and extracellular matrix proteins.1

    • viral3

      Offers anti-inflammatory, anti-bacterial, re-epithelialization, and anti-fibrotic properties.2,3

    • viral4

      Has published studies on its benefits and efficacy in woundcare dating back over 100 years.4

    • viral5

      Mitigates the expression of class II antigens, minimizing immunogenicity and reducing the risk of adverse reaction.5

    Q: What ECM Proteins are Found in Amniotic Tissue?

    Amniotic tissue is known to contain the following extracellular matrix elements:

    • Collagen Types, I, III, IV, V and VII
    • Laminin
    • Tissue Inhibitors of Metalloproteinases (TIMPs)
    • Fibronectin
    • Proteoglycans
    • Hyaluronic Acid

    Q: What Growth Factors are Found in Amniotic Tissue?

    Human amniotic tissue is known to contain the following growth factors:

    • FGF — Fibroblast Growth Factor
    • EGF — Epidermal Growth Factor
    • VEGF — Vascular Endothelial Growth Factor
    • TGF-β1 — Transforming Growth Factor beta 1
    • PDGF– Platelet-Derived Growth Factor AA and BB
    • Cytokines

    Amniotic Tissue Allografts

    Q: What are Amniotic Tissue Allografts?

    Amniotic tissue allografts are human amniotic fluid and/or amniotic membrane tissues that have been minimally manipulated into a liquid or patch format.

    Amniotic tissue allografts can be placed on or around a wound to serve the same function that they do in utero, which is to cover, protect and nourish tissue. Amniotic tissue makes an attractive wound biomaterial, not only for it’s natural ability to cover and protect, but also for its unique make-up of growth factors, cytokines and anti-inflammatory properties – factors all known to be critical in wound healing.


    Surgilogix offers four human amniotic tissue allografts: AmnioFLEX, SXFluid, SXMatrix, and SXBarrier.

    Q: On What Type of Wounds can you apply Amniotic Tissue Allografts?

    Regenerative amniotic tissue allografts have been used successfully in wound care to cover and aid in healing a variety of wound types both topically and in vivo, including:

    • Incision wounds made during open, laproscopic or DiVinci System® surgical procedures
    • Trauma wounds caused by an accident or repeated use
    • Hard to heal or chronic wounds, like diabetic ulcers

    Q: Are Amniotic Tissue Allografts Safe?

    Safe Tissue Handling

    • Procurement is done by qualified partners following stringent protocols.
    • Donors are pre-screened through an intensive medical review and prenatal examination.
    • Communicable disease testing is performed by an FDA-registered, CLIA laboratory.
    • Allografts are subjected to stringent USP testing prior to release.

    Patient Reaction

    • Class II antigen expression is mitigated in amniotic tissue minimizing immunogenicity and reducing the risk of graft versus host reaction.⁵
    • Unlike other amniotic tissue allografts on the market, Surgilogix allografts do not contain chorion, further reducing the risk of an adverse reaction.
    • Amniotic tissue has been used in wound care for over 100 years.
    • There have been no reported adverse reactions to Surgilogix allografts.
    Download the complete details in our brochure titled, “Understanding the Safety & Make-up of Amniotic Tissue.”

    Q: How are Amniotic Tissue Allografts Storaged and When Do They Expire?

    Storage conditions and expiry dates are determined by the allograft type. Surgilogix’s amnion-derived allografts fall into three storage categories: cryo-frozen (-80°C+/-15°C), refrigerated (2 – 8°C) or ambient/room temperature (15 – 30°C).


    *Expiry times are only valid if the allograft is stored under recommended storage conditions.

    Allograft Type Preservation Technique Proper
    Storage Conditions
    Typical Expiry*
    SXFluid/
    AmnioFLEX
    Cryopreserved -80°C+/-15°C 2 years
    SXMatrix AdvanTek -80°C+/-15°C
    2 – 8°C
    15 – 30°C
    2 years
    14 days
    24 hours
    SXBarrier Gamma
    Irradiated
    Ambient 2 years

    Q: Why choose Amniotic Tissue Allografts from SurgiLogix?

    Our focus on the true science behind amniotic tissue and allograft technologies has allowed us to produce superior products.

    • Chorion Removal – Research has shown that chorion contains
      maternal antigens that may trigger an immune reaction. To improve safety, we remove the chorion from all amniotic tissues used in SurgiLogix allografts. Over 55,000 patients have been treated with these chorion-free allografts and with no known adverse events.
    • Processing Technique – Our scientists have spent countless hours refining our processing technique in order to maintain the viability and concentration of the key healing properties found in amniotic tissue.

    DBM Allografts

    Q: How does allograft bone compare to autogenous bone grafts?

    SXDBM™ is an effective alternative to autogenous bone grafts.

    It is available in large quantities, does not require harvesting from the patient, and contains a rich quantity of bone morphogenetic proteins, which belong to the transforming growth factor superfamily of proteins.

    *Please note that throughout the site we use the term allograft in lieu of graft. The word graft is often used interchangeably with allograft, however, graft is defined as a piece of living tissue that is transplanted surgically. The word allograft further differentiates that the tissues come from the same species as the recipient but is not genetically identical.

    References
    1 Complements and the Wound Healing Cascade: An Updated Review. Hani Sinno and S atya Prakash. Plast Surg Int. 2013; 2013: 146764
    2 Amniotic Fluid: Not Just Fetal Urine Anymore. Mark A Underwood, William M Gilbert, Michael P Sherman. Journal of Perinatology. 2005; 25: 341-348
    3 Growth factors and cytokines in wound healing. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Wound Repair Regen. 2008; 16(5): 585-601
    4 The Grafting of Preserved Amniotic Membrane to Burned and Ulcerated Surfaces, Substituting Skin Grafts: A Preliminary Report. Maximilian Stern. JAMA. 1913; 60(13): 973-974
    5 Immunological characteristics of amniotic epithelium. Hori J, Wang M, Kamiya K, Takahashi H, Sakuragawa N. Cornea. 2006; 25(10): S53-58